Home
Market Capitalization of Transgene Biotek Ltd

Transgene Biotek Ltd
NSE: TRANSGENEBIOTEK
Market Cap
Key Highlights
- The Market Cap of Transgene Biotek Ltd is ₹ 32.05 crore as of 21 Feb 25 .
- The Latest Trading Price of Transgene Biotek Ltd is ₹ 4.23 as of 21 Feb 15:30 .

Transgene Biotek Ltd
NSE: TRANSGENEBIOTEK
Share Price
Market Price of Transgene Biotek Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 4.23 |
20 Feb 2025 | 4.25 |
19 Feb 2025 | 4.25 |
18 Feb 2025 | 4.06 |
17 Feb 2025 | 4.2 |
14 Feb 2025 | 4.4 |
13 Feb 2025 | 4.31 |
12 Feb 2025 | 4.43 |
11 Feb 2025 | 4.34 |
10 Feb 2025 | 4.47 |
SWOT Analysis Of Transgene Biotek Ltd
BlinkX Score for Transgene Biotek Ltd
Asset Value vs Market Value of Transgene Biotek Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Transgene Biotek Ltd
Historical P/E Ratio of Transgene Biotek Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Transgene Biotek Ltd
Historical Revenue of Transgene Biotek Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Transgene Biotek Ltd
Historical EBITDA of Transgene Biotek Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Transgene Biotek Ltd
Historical Net Profit of Transgene Biotek Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Transgene Biotek Ltd
Dividend Payout Over Time
About Transgene Biotek Ltd
- Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India.
- Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
- The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.
Transgene Biotek Ltd News Hub
Transgene Biotek reports consolidated net profit of Rs 0.20 crore in the June 2024 quarter
Net profit of Transgene Biotek reported to Rs 0.20 crore in the quarter ended June 2024 as against n
Read more
12 Aug 24
Transgene Biotek to announce Quarterly Result
Transgene Biotek will hold a meeting of the Board of Directors of the Company on 12 November 2024 Po
Read more
05 Nov 24
Transgene Biotek reports consolidated net loss of Rs 0.07 crore in the September 2024 quarter
Net Loss of Transgene Biotek reported to Rs 0.07 crore in the quarter ended September 2024 as agains
Read more
12 Nov 24
Transgene Biotek declare Quarterly Result
Transgene Biotek will hold a meeting of the Board of Directors of the Company on 24 January 2025. Po
Read more
17 Jan 25